Vistagen Therapeutics, Inc. (VTGN)

NASDAQ: VTGN · Real-Time Price · USD

Compare

0.5300

+0.0244 (4.83%)

At close: Feb 17, 2026, 4:00 PM EST

0.5474

+0.0174 (3.28%)

Pre-market: Feb 18, 2026, 4:29 AM EST

Vistagen Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	47.37	67.13	119.17	16.64	68.14	103.11
Short-Term Investments	14.4	13.35	-	-	-	-
Cash & Short-Term Investments	61.77	80.48	119.17	16.64	68.14	103.11
Cash Growth	-30.25%	-32.46%	616.23%	-75.58%	-33.92%	7508.91%
Other Receivables	-	-	-	-	0.34	0.04
Receivables	-	-	-	-	0.34	0.04
Prepaid Expenses	1.48	1.59	1.51	0.8	0.2	0.12
Other Current Assets	-	-	-	0.07	2.33	0.85
Total Current Assets	63.25	82.08	120.67	17.51	71	104.12
Property, Plant & Equipment	1.42	1.81	2.26	2.77	3.08	3.59
Long-Term Deferred Charges	-	-	-	0.71	0.47	0.53
Other Long-Term Assets	0.39	0.45	0.73	0.1	0.1	0.05
Total Assets	65.06	84.34	123.65	21.09	74.64	108.28
Accounts Payable	1.28	0.65	1.55	2.47	2.76	0.84
Accrued Expenses	9.25	8.81	2.24	0.8	1.33	1.56
Short-Term Debt	0.38	-	-	0.11	-	-
Current Portion of Leases	0.62	0.56	0.55	0.49	0.43	0.37
Current Unearned Revenue	2	2.59	0.79	0.71	1.24	1.42
Total Current Liabilities	13.53	12.61	5.12	4.57	5.77	4.19
Long-Term Leases	0.43	0.95	1.57	2.12	2.61	3.35
Long-Term Unearned Revenue	0.18	0.39	2.67	2.32	1.56	2.49
Total Liabilities	14.14	13.95	9.37	9.01	9.93	10.03
Common Stock	0.04	0.03	0.03	0.01	0.01	0.18
Additional Paid-In Capital	515.88	481.96	474.44	342.89	336.28	315.6
Retained Earnings	-461.04	-407.63	-356.21	-326.85	-267.6	-219.84
Treasury Stock	-3.97	-3.97	-3.97	-3.97	-3.97	-3.97
Comprehensive Income & Other	0.01	0.01	-	-	-	-
Total Common Equity	50.92	70.39	114.29	12.08	64.72	91.97
Shareholders' Equity	50.92	70.39	114.29	12.08	64.72	98.25
Total Liabilities & Equity	65.06	84.34	123.65	21.09	74.64	108.28
Total Debt	1.43	1.51	2.12	2.71	3.04	3.72
Net Cash (Debt)	60.34	78.97	117.05	13.93	65.1	99.39
Net Cash Growth	-30.52%	-32.53%	740.43%	-78.61%	-34.50%	-
Net Cash Per Share	1.71	2.56	6.05	2.00	9.86	34.62
Filing Date Shares Outstanding	39.62	29.16	27.03	7.87	6.89	6.38
Total Common Shares Outstanding	39.62	29	27.03	7.31	6.88	6.02
Working Capital	49.72	69.46	115.55	12.93	65.23	99.93
Book Value Per Share	1.29	2.43	4.23	1.65	9.40	15.28
Tangible Book Value	50.92	70.39	114.29	12.08	64.72	91.97
Tangible Book Value Per Share	1.29	2.43	4.23	1.65	9.40	15.28
Machinery	-	1.6	1.48	1.49	1.45	1.29
Leasehold Improvements	-	0.22	0.21	0.21	0.21	0.21

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q